Effect of Sodium Nitroprusside on Cerebral Blood Flow

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

December 4, 2017

Study Completion Date

December 4, 2017

Conditions
Healthy Male Subjects
Interventions
OTHER

Hyperventilation

The subject is instructed to hyperventilate for 6 min to provoke a 0.7-1.2 kPa reduction in PaCO2, and the evaluation is repeated if the reduction in PaCO2 is not within this interval. The order of hyperventilation and 6% CO2 breathing is randomized.

OTHER

6% CO2 breathing

The subject breathes a mixture of 6% CO2 (with 21% O2 and 73% N2) from a bag and a face mask for 6 minutes. The order of hyperventilation and 6% CO2 breathing is randomized.

DRUG

Infusion of sodium nitroprusside

Using incremental intravenous infusion of sodium nitroprusside MAP is reduced by 20% (15%-25%) and then by 40% (35%-45%, MAP minimally at 50 mmHg).

Trial Locations (1)

DK-2100

Department of Anesthesia, Rigshospitalet 2043, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03317652 - Effect of Sodium Nitroprusside on Cerebral Blood Flow | Biotech Hunter | Biotech Hunter